Want to see TSE:GLOW full AI Analyst Report?
GLOW Stock Chart & Stats
C$0.04
C$0.00(0.00%)
At close: 4:00 PM EDT
C$0.04
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.04 - C$0.08
Previous CloseN/A
Volume19.80K
Average Volume (3M)266.05K
Market Cap
C$8.66M
Enterprise ValueC$8.51
Total Cash (Recent Filing)C$1.59M
Total Debt (Recent Filing)C$45.48K
Price to Earnings (P/E)―
Beta-0.06
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding192,435,550
10 Day Avg. Volume165,602
30 Day Avg. Volume266,047
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)3.82
Price to Sales (P/S)5.04
P/FCF Ratio-87.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthTTM revenue is up meaningfully versus the latest annual period, with growth accelerating. This expands the potential operating base and indicates stronger commercial traction; if sustained, scale could improve fixed-cost absorption and support eventual profitability.
Narrowing LossesLoss intensity has improved compared with 2024, showing progress in financial performance despite continued losses. Sustained margin improvement could reduce future funding needs and demonstrate movement toward a more viable operating model.
Low LeverageVery low debt relative to equity limits interest and refinancing pressure, preserving financial flexibility. This gives the company more capacity to fund product development and commercial expansion while it works toward positive earnings and cash flow.
Bears Say
Persistent Cash BurnNegative operating and free cash flow indicate that the business is not yet self-funding. Continued cash burn may require external financing or existing reserves, creating dilution, liquidity and execution risks until cash generation becomes sustainable.
Unproven ProfitabilityThe company remains in a heavy investment and burn phase without positive operating profit or EBITDA. This limits internal funding capacity and leaves the long-term business model unproven, even though revenue and loss trends have improved.
Balance-Sheet VolatilityA prior period of negative equity and continuing losses indicate that balance-sheet strength has not been consistently established. If losses persist, renewed equity erosion could weaken financing flexibility and increase dependence on external capital.
GLOW FAQ
What was Glow LifeTech’s price range in the past 12 months?
Glow LifeTech lowest stock price was C$0.04 and its highest was C$0.07 in the past 12 months.
What is Glow LifeTech’s market cap?
Glow LifeTech’s market cap is C$8.66M.
When is Glow LifeTech’s upcoming earnings report date?
Glow LifeTech’s upcoming earnings report date is Sep 01, 2026 which is in 10 days.
How were Glow LifeTech’s earnings last quarter?
Currently, no data Available
Is Glow LifeTech overvalued?
According to Wall Street analysts Glow LifeTech’s price is currently Overvalued.
Does Glow LifeTech pay dividends?
Glow LifeTech does not currently pay dividends.
What is Glow LifeTech’s EPS estimate?
Glow LifeTech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Glow LifeTech have?
Glow LifeTech has 192,435,550 shares outstanding.
What happened to Glow LifeTech’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Glow LifeTech?
Currently, no hedge funds are holding shares in TSE:GLOW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Glow LifeTech
Glow Lifetech Corp. is a biotechnology enterprise based in North America, dedicated to the development and marketing of nutraceutical and cannabinoid-derived products. The company is actively commercializing two core technologies: MyCell Enhanced technology, which facilitates the optimal delivery of nutrients for both nutraceuticals and cannabis, and a Cannabis Smart Consumption System, designed to help users and patients store, track, manage, and consume cannabis products effectively. Glow Lifetech possesses exclusive rights throughout North America for the production, sale, and distribution of a specific micellization technology, applicable to cannabis and hemp-derived ingredients, curcumin, Vitamin K, and iron. A key aspect of their operations involves the advanced processing of ingredients, converting certain vitamins, nutraceuticals, and cannabis extracts into micellized forms. This process significantly boosts the bioavailability of fat-soluble compounds, ensuring near 100% absorption into the body and enhancing their compatibility with water. The company, founded in 2018, is headquartered in Toronto, Canada.
Technical Analysis
COSCIENS Biopharma
―
Kane Biotech
―
Quest Pharmatech
―
PreveCeutical Medical
―
PharmAla Biotech Holdings, Inc.
―






